---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-23-188223"
form_type: "8-K"
ticker: "IKT"
cik: "0001750149"
company_name: "Inhibikase Therapeutics, Inc."
filed_at: "2023-07-17T23:59:59+00:00"
generated_at: "2026-06-13T07:47:30.654480+00:00"
event_type: "regulatory"
sentiment: "positive"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Inhibikase regains Nasdaq minimum bid price compliance

## Summary
- Received Nasdaq notice on July 17, 2023 confirming compliance with Listing Rule 5550(a)(2).
- Closing bid price was at or above $1.00 for 10 consecutive business days ended July 14, 2023.
- The matter is closed; no further action required from the company.

## SEC filing metadata
- accession: 0001193125-23-188223
- form_type: 8-K
- ticker: IKT
- cik: 0001750149
- company_name: Inhibikase Therapeutics, Inc.
- filed_at: 2023-07-17T23:59:59+00:00
- event_type: regulatory
- sentiment: positive
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1750149/000119312523188223/0001193125-23-188223-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1750149/000119312523188223/d510291d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-23-188223
- JSON: https://secwatch.observer/filing/0001193125-23-188223.json
- Plain text: https://secwatch.observer/filing/0001193125-23-188223.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.